UN reports 2,325 Ebola deaths in DRC, highest in country’s history.

The United Nations has announced that the current Ebola virus outbreak in the Democratic Republic of Congo (DRC) has claimed at least 2,325 lives, the highest death toll recorded in the country’s history. The figures, released on Tuesday, were compiled by the UN’s Office for the Coordination of Humanitarian Affairs (OCHA) after a review of data from the Congolese Ministry of Health, the World Health Organization (WHO), and partner agencies operating in the affected provinces of North Kivu, Ituri, and South Kivu.

Ebola first appeared in the DRC in 1976 and has since caused more than 30 outbreaks, with the most recent wave beginning in late 2022 in the eastern regions of the country. The virus spreads through contact with bodily fluids of infected individuals and is highly contagious in settings where health infrastructure is weak. The current outbreak has been driven by a combination of factors, including delayed case detection, limited laboratory capacity, and ongoing armed conflict that hampers access to affected communities. The UN’s report notes that the death toll is concentrated in communities with limited health facilities, where the ratio of healthcare workers to patients remains low.

The DRC government has pledged to intensify its response, but it faces significant logistical challenges. President Félix Tshisekedi’s administration has requested additional resources from international partners, and the Ministry of Health has been working with WHO to expand vaccination campaigns using the rVSV-ZEBOV vaccine, which has proven effective in past outbreaks. Meanwhile, the WHO has deployed field teams to support contact tracing and to reinforce infection‑control measures in hospitals and clinics. According to the agency, more than 100,000 people have been vaccinated so far, but the pace of vaccination is constrained by supply shortages and security concerns.

On the international front, the United Nations has called for a coordinated effort to curb the spread of the virus. The UN Secretariat’s humanitarian coordinator for Africa, Maryam Al‑Bukhari, said that “the scale of the crisis demands a unified response that includes increased funding, expanded laboratory testing, and the deployment of mobile medical units.” The UN’s Department of Global Affairs has also urged donor countries to meet the $1.5 billion funding gap identified in the UN’s latest assessment. Several major donors, including the United States, the European Union, and China, have pledged financial and technical support, though the distribution of aid remains uneven across the affected provinces.

The outbreak’s impact extends beyond the immediate health crisis. The DRC is a major producer of cobalt, a critical raw material for batteries used in electric vehicles and smartphones. Disruptions in local production and export logistics could ripple through global supply chains, affecting the semiconductor and renewable‑energy sectors worldwide. Moreover, the international community’s response to the DRC outbreak underscores the importance of strengthening global health security mechanisms, a priority highlighted in the WHO’s 2021 Global Health Security Agenda. The outbreak serves as a stark reminder that emerging infectious diseases can rapidly cross borders, necessitating robust surveillance, rapid diagnostics, and coordinated vaccine deployment.

For Taiwan, the situation highlights the interconnected nature of global health and the need for resilient supply chains. Taiwan’s semiconductor industry relies heavily on cobalt and other minerals sourced from Africa, and any supply chain disruptions could affect production timelines for electronics and battery components. Additionally, Taiwan’s own public health agencies monitor international disease outbreaks to anticipate potential importation risks. While the outbreak remains geographically contained, the broader lesson is that health crises can have far‑reaching economic and security implications, reinforcing the value of international cooperation and investment in disease‑control infrastructure.